Identifying Individuals at High Risk of Melanoma: A Practical Predictor of Absolute Risk
- 1 August 2006
- journal article
- melanoma
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (22) , 3590-3596
- https://doi.org/10.1200/jco.2005.04.1277
Abstract
Purpose: We developed a model to estimate the 5-year absolute risk of melanoma to efficiently identify individuals at increased risk of melanoma for potential interventions. Patients and Methods: We used data from a case-control study with 718 non-Hispanic white patients with invasive cutaneous melanoma from melanoma clinics in Philadelphia, PA and San Francisco, CA; matched controls were 945 patients from outpatient clinics with similar catchment areas. All participants underwent extensive interviews and skin examinations. We selected easily obtained clinical characteristics and responses to simple questions for study in order to develop sex-specific relative risk models. These models were combined with incidence and mortality rates by United States geographic areas to develop estimates of the absolute risk of developing melanoma within 5 years. Results: Relative risk models yielded an attributable risk of 86% for men and 89% for women, using at most seven variables. Attributable risks did not vary by age, ultraviolet B flux or hours outdoors. The absolute individual risks varied widely, depending on age, other host characteristics, and geographic area. Individual absolute risk can be estimated using a program available online. Conclusion: Our procedures allow for estimating the absolute risk of developing melanoma to assist in the identification of patients at high risk. Such high-risk individuals could undergo interventions including a complete skin examination, counseling to avoid sun exposures, regular self and professional surveillance, or participation in prevention trials. It is important to emphasize that these projections are not intended to identify current melanoma cases.Keywords
This publication has 20 references indexed in Scilit:
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- Cutaneous melanoma: pathogenesis and rationale for chemopreventionCritical Reviews in Oncology/Hematology, 2005
- A new hepatic artery infusion modelJournal of Clinical Oncology, 2004
- Determining the maximum tolerated frequency (MTF) of intraperitoneal fluorouracil/folinic acid (FU/FA) administered with adjuvant intravenous FU/FA in patients with colorectal and upper GI tumoursJournal of Clinical Oncology, 2004
- Screening for melanomaDermatologic Clinics, 2002
- Final Version of the American Joint Committee on Cancer Staging System for Cutaneous MelanomaJournal of Clinical Oncology, 2001
- Is Routine Screening for Melanoma a Benign Practice?Published by American Medical Association (AMA) ,2000
- Counseling and DNA Testing for Individuals Perceived to Be Genetically Predisposed to Melanoma: A Consensus Statement of the Melanoma Genetics ConsortiumJournal of Clinical Oncology, 1999
- Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groupsThe Lancet, 1993
- Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier diseaseJournal of the American Academy of Dermatology, 1990